# Astrazeneca sinks 3% premarket after rare disease drug approved for fourth indication in China
**Why is it moving?**

**2023-10-18 11:45**

**https://www.ainvest.com/news/astrazeneca-sinks-3-premarket-after-rare-disease-drug-approved-for-fourth-indication-in-china-2310100002dc9b47570628f2/**

Astrazeneca sinks 3% premarket after rare disease drug approved for fourth indication in China